Search
for
Sort by
Research 631–660 of 652
- Cutaneous Side Effects of Modern Targeted Therapy and Immunotherapy in Patients with Dermatological Malignancies
- Study on Autoimmune Thyroid Disorders in Chronic Spontaneous Urticaria at a Tertiary Care Central Rural Hospital in India
- Dermatologic manifestations of thyroid disease: a literature review
- Use of Contact Immunotherapy in the Treatment of Skin Diseases Other than Alopecia Areata
- 1,314
- [Translated article] Keys to the Diagnosis of Hair Shaft Disorders: Part II
- Circle Hairs in a Patient with Multiple Myeloma
- Adnexotropic Variants of the Interface Dermatitides: A Review
- Skin Manifestations of Rheumatological Diseases
- Author response: Type XVII collagen coordinates proliferation in the interfollicular epidermis
- Decision letter: Type XVII collagen coordinates proliferation in the interfollicular epidermis
- Proceedings of the Ninth World Congress for Hair Research (2015)
- 25-Year-Old Woman With New-Onset Seizures
- Subject Index
- Viewpoint 2
- TONGUE, RED
- Author Index
- Dermatologic therapy: December 1984 through December 1985
- The Wnt inhibitor, Dickkopf 4, is induced by canonical Wnt signaling during ectodermal appendage morphogenesis
- Secondary Syphilis in Cali, Colombia: New Concepts in Disease Pathogenesis
- IL-36γ drives skin toxicity induced by EGFR/MEK inhibition and commensal Cutibacterium acnes
- Viva questions from the IJDVL
- The spectrum of cutaneous adverse events during encorafenib and binimetinib treatment in B‐rapidly accelerated fibrosarcoma‐mutated advanced melanoma
- Chemotherapy-induced dermatological toxicity: frequencies and impact on quality of life in women’s cancers. Results of a prospective study
- Dermatological adverse events with taxane chemotherapy
- Cutaneous Drug Reaction Case Reports
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Cutaneous reactions to chemotherapeutic drugs and targeted therapy for cancer
- Cutaneous drug reactions
- The Cutaneous Side Effects of Selective BRAF Inhibitors and Anti-CTLA4 Agents: the Growing Role of the Dermatologist in the Management of Patients with Metastatic Melanoma